权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

RAPID ACCELERATION OF DIAGNOSTICS (RADX) CLINICAL EVALUATION SERVICES--TASK AREA A, ADMINISTRATIVE SUPPORT

快速加速诊断 (RADX) 临床评估服务 - 任务领域 A，行政支持

基本信息

批准号：
10506147
负责人：
MARK MARINO
金额：
$ 73.39万
依托单位：
VENTUREWELL
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-02-17 至 2022-02-16
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10506147
关键词：
American Area COVID-19 COVID-19 detection COVID-19 diagnostic COVID-19 testing Centers for Disease Control and Prevention (U.S.)Clinical Contracts Department of Defense Development Device Designs Diagnostic tests Ensure Exhalation Funding Goals Home Improve Access Laboratories Life Cycle Stages Modification National Institute of Biomedical Imaging and Bioengineering Patients Performance Point of Care Technology Privatization Program Development RADx Readiness Research Saliva Sampling Seasons Sensitivity and Specificity Services Speed Structure Technology Test Result Testing Time TimeLine United States National Institutes of Health Validation Virus base commercialization cost design detection limit flu handheld mobile device home test improved innovation meetings novel point of care product development programs research clinical testing scale up technology development user-friendly

项目摘要

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has an open solicitation for proposals to provide up to $500 million across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN). RADx will support novel solutions that build the U.S. capacity for SARS-CoV-2 testing up to 100-fold above what is achievable with standard approaches. RADx is structured to deliver innovative testing strategies to the public as soon as late summer 2020 and is an accelerated and comprehensive multi-pronged effort by NIH to make SARS-CoV-2 testing readily available to every American.

美国国家生物医学成像和生物工程研究所（NIBIB）公开征求建议，为多个项目提供高达5亿美元的资金，以快速生产创新的SARS-CoV-2诊断检测试剂盒，帮助公众安全恢复正常活动。快速加速诊断（RADx）是一项利用美国国立卫生研究院（NIH）即时护理技术研究网络（POCTRN）的快速技术开发计划。RADx将支持新的解决方案，使美国的SARS-CoV-2检测能力提高到标准方法的100倍。RADx的结构是最早在2020年夏末向公众提供创新的检测策略，这是美国国立卫生研究院加速和全面的多管齐下的努力，目的是让每个美国人都能随时获得SARS-CoV-2检测。